Old LJ - Search Results

1

The cancer/testis genes: review, standardization, and commentary.

Scanlan MJ, Simpson AJ, Old LJ. Scanlan MJ, et al. Among authors: old lj. Cancer Immun. 2004 Jan 23;4:1. Cancer Immun. 2004. PMID: 14738373 Review.

2

Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases.

Varga Z, Theurillat JP, Filonenko V, Sasse B, Odermatt B, Jungbluth AA, Chen YT, Old LJ, Knuth A, Jäger D, Moch H. Varga Z, et al. Among authors: old lj. Clin Cancer Res. 2006 May 1;12(9):2745-51. doi: 10.1158/1078-0432.CCR-05-2192. Clin Cancer Res. 2006. PMID: 16675566

3

CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients.

Nishikawa H, Jäger E, Ritter G, Old LJ, Gnjatic S. Nishikawa H, et al. Among authors: old lj. Blood. 2005 Aug 1;106(3):1008-11. doi: 10.1182/blood-2005-02-0607. Epub 2005 Apr 19. Blood. 2005. PMID: 15840697

4

Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.

Matsuzaki J, Tsuji T, Luescher I, Old LJ, Shrikant P, Gnjatic S, Odunsi K. Matsuzaki J, et al. Among authors: old lj. Cancer Immunol Res. 2014 Apr;2(4):341-50. doi: 10.1158/2326-6066.CIR-13-0138. Epub 2013 Dec 17. Cancer Immunol Res. 2014. PMID: 24764581 Free PMC article.

5

NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells.

Gnjatic S, Altorki NK, Tang DN, Tu SM, Kundra V, Ritter G, Old LJ, Logothetis CJ, Sharma P. Gnjatic S, et al. Among authors: old lj. Clin Cancer Res. 2009 Mar 15;15(6):2130-9. doi: 10.1158/1078-0432.CCR-08-2632. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276258 Free PMC article. Clinical Trial.

6

LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.

Bender A, Karbach J, Neumann A, Jäger D, Al-Batran SE, Atmaca A, Weidmann E, Biskamp M, Gnjatic S, Pan L, Hoffman E, Old LJ, Knuth A, Jäger E. Bender A, et al. Among authors: old lj. Cancer Immun. 2007 Oct 19;7:16. Cancer Immun. 2007. PMID: 17944437 Free PMC article. Clinical Trial.

7

T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.

Uenaka A, Wada H, Isobe M, Saika T, Tsuji K, Sato E, Sato S, Noguchi Y, Kawabata R, Yasuda T, Doki Y, Kumon H, Iwatsuki K, Shiku H, Monden M, Jungbluth AA, Ritter G, Murphy R, Hoffman E, Old LJ, Nakayama E. Uenaka A, et al. Among authors: old lj. Cancer Immun. 2007 Apr 19;7:9. Cancer Immun. 2007. PMID: 17441676 Free PMC article. Clinical Trial.

8

A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients.

Ayyoub M, Souleimanian NE, Godefroy E, Scotto L, Hesdorffer CS, Old LJ, Valmori D. Ayyoub M, et al. Among authors: old lj. Clin Immunol. 2006 Feb-Mar;118(2-3):188-94. doi: 10.1016/j.clim.2005.10.002. Epub 2005 Dec 20. Clin Immunol. 2006. PMID: 16368270

9

Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.

Jäger D, Karbach J, Pauligk C, Seil I, Frei C, Chen YT, Old LJ, Knuth A, Jäger E. Jäger D, et al. Among authors: old lj. Cancer Immun. 2005 Dec 12;5:11. Cancer Immun. 2005. PMID: 16335914

10

Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.

Karbach J, Pauligk C, Bender A, Gnjatic S, Franzmann K, Wahle C, Jäger D, Knuth A, Old LJ, Jäger E. Karbach J, et al. Among authors: old lj. Int J Cancer. 2006 Feb 1;118(3):668-74. doi: 10.1002/ijc.21391. Int J Cancer. 2006. PMID: 16152624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results